Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization

Cardiovascular Research

Volumn 88, Issue 1, 2010, Pages 186-195

  Cochain, Clément ^a   Rodero, Mathieu P ^a   Vilar, José ^a   Récalde, Alice ^a   Richart, Adle L ^a   Loinard, Céline ^a   Zouggari, Yasmine ^a   Guérin, Coralie ^a   Duriez, Micheline ^a   Combadire, Behazine ^a   Poupel, Lucie ^a   Lévy, Bernard I ^a   Mallat, Ziad ^a,b   Combadire, Christophe ^a   Silvestre, Jean Sébastien ^a  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiogenesis; Arteriogenesis; Inflammation; Ischaemia; Monocyte subset

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; RANTES;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; BLOOD FLOW; CELL COUNT; ENZYME ACTIVATION; GENE OVEREXPRESSION; HINDLIMB; ISCHEMIA; MALE; MONOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, LY; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CX3CL1; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; HINDLIMB; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; RECEPTORS, CCR2; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 77956818198     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq153     Document Type: Article

References (29)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
2. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A et al. Impaired arter-iogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 2003; 108:205-210.
3. Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U et al. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation 2006;113:118-124.
4. Van Weel V, Toes RE, Seghers L, Deckers MM, De Vries MR, Eilers PH et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 2007;27:2310-2318.
5. Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard C, Cochain C et al. Regulatory T cells modulate postischemic neovascularization. Circulation 2009;120:1415-1425.
6. Heissig B, Rafii S, Akiyama H, Ohki Y, Sato Y, Rafael T et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 2005;202:739-750.
7. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 2004;95:449-458.
8. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2004;94:262-268.
9. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82.
10. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-692.
11. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007;317:666-670.
12. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037-3047.
13. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, Pezard A et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007;117: 2920-2928.
14. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005;8:211-226.
15. Capoccia BJ, Gregory AD, Link DC. Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J Leukoc Biol 2008;84:760-768.
16. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004;94:671-677.
17. Waeckel L, Bignon J, Liu JM, Markovits D, Ebrahimian TG, Vilar J et al. Tetrapeptide AcSDKP induces postischemic neovascularization through monocyte chemoattrac-tant protein-1 signaling. Arterioscler Thromb Vasc Biol 2006;26:773-779.
18. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009;325:612-616.
19. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007;117:185-194.
20. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocy-tosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008;117:1649-1657.
21. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007;117:902-909.
22. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006;7:311-317.
23. Engel DR, Maurer J, Tittel AP, Weisheit C, Cavlar T, Schumak B et al. CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J Immunol 2008;181:5579-5586.
24. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002;283:H2411-H2419.
25. Magri D, Vasilas P, Muto A, Nishibe T, Dardik A. Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery. J Surg Res 2009;158:1-11.
26. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009;113:963-972.
27. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744.
28. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008;13:206-220.
29. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, Drevets DA et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004;172:4410-4417.